ボツリヌストキシンのアジア太平洋市場2021-2028

◆英語タイトル:ASIA-PACIFIC BOTULINUM TOXIN MARKET FORECAST 2021-2028
◆商品コード:INK21JU041
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年5月3日
◆ページ数:137
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはボツリヌストキシンのアジア太平洋市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、種類別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況などを掲載したものです。
【レポートの概要】

KEY FINDINGSThe Asia-Pacific botulinum toxin market is forecasted to develop with a CAGR of 5.83% during the reviewed period of 2021 to 2028. The market growth of the region is ascribed to the population’s increasing awareness and interest in cosmetic procedures, the surge in the aging population, and the growing purchasing power of the middle class, owing to swift economic advancements.
MARKET INSIGHTS
The Asia-Pacific botulinum toxin market growth assessment entails the in-depth analysis of Australia & New Zealand, Vietnam, China, Thailand, South Korea, Japan, India, Indonesia, and the rest of the Asia-Pacific. As per the International Society of Aesthetic Plastic Surgery (ISAPS), the cosmetic surgery market in South Korea comprises over 2,000 plastic surgery clinics, with an estimated total revenue of $10 billion. Moreover, South Korea has often made it to ISAP’s top five countries in terms of the number of cosmetic procedures performed in the present decade. The nation recorded around 4,788,000 international patients across its plastic and cosmetic surgery departments in 2016, indicating a significant increase than the previous year.
On the other hand, Singapore is one of the key countries, accounting for the highest economic losses on account of migraines. According to a study conducted by the NUS Medical School Singapore in 2018, the total lifetime incidence of headaches in the nation was over 82%, out of which, migraines constituted 9.3%. This aspect has necessitated the demand for adequate migraine treatments, as well. Therefore, such factors play a crucial role in supplementing the botulinum market in the Asia-Pacific over the forecasting years.
COMPETITIVE INSIGHTS
Prominent companies operating in the market are Ipsen Pharma, Medytox, Allergan PLC, Hugel Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. RELATED MARKET ANALYSIS: AESTHETIC FILLER MARKET
3.2. KEY DRIVERS
3.2.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
3.2.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
3.3. KEY RESTRAINTS
3.3.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
3.3.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
3.3.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY TYPE
5.1. TYPE A
5.2. TYPE B
6. MARKET BY APPLICATION
6.1. COSMETIC APPLICATIONS
6.1.1. GLABELLAR LINES
6.1.2. LATERAL CANTHAL LINES (CROW’S FEET)
6.1.3. FOREHEAD LINES
6.1.4. OTHER COSMETIC APPLICATIONS
6.2. NON-COSMETIC APPLICATIONS
6.2.1. DYSTONIA
6.2.2. CHRONIC MIGRAINE
6.2.3. OPHTHALMOLOGIC DISORDERS
6.2.4. OTHER NON-COSMETIC APPLICATIONS
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND OTHERS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. KEY GROWTH ENABLERS
8.1.2. KEY CHALLENGES
8.1.3. KEY PLAYERS
8.1.4. COUNTRY ANALYSIS
8.1.4.1. CHINA
8.1.4.2. JAPAN
8.1.4.3. INDIA
8.1.4.4. SOUTH KOREA
8.1.4.5. SINGAPORE
8.1.4.6. THAILAND
8.1.4.7. VIETNAM
8.1.4.8. AUSTRALIA & NEW ZEALAND
8.1.4.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC (ALLERGAN PLC)
9.2.2. EVOLUS INC
9.2.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
9.2.4. HUGEL INC
9.2.5. IPSEN PHARMA
9.2.6. MEDYTOX INC
9.2.7. MERZ PHARMA
9.2.8. REVANCE THERAPEUTICS INC
9.2.9. US WORLDMEDS LLC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN
TABLE 2: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: ASIA-PACIFIC BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020
FIGURE 6: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
FIGURE 9: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 20: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 23: CHINA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 24: JAPAN BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 25: INDIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 26: SOUTH KOREA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: INDONESIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: THAILAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: VIETNAM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ボツリヌストキシンのアジア太平洋市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆